Qube Research & Technologies (QRT)
APYX icon

Qube Research & Technologies (QRT)’s Apyx Medical APYX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.3K Sell
11,652
-68,736
-86% -$273K ﹤0.01% 3118
2026
Q1 		$297K Sell
80,388
-13,291
-14% -$49.7K ﹤0.01% 2867
2025
Q4 		$328K Buy
+93,679
New +$327K ﹤0.01% 2925
2024
Q3 		– Sell
-285
Closed -$382 – 3276
2024
Q2 		$382 Sell
285
-62,543
-100% -$92.3K ﹤0.01% 3332
2024
Q1 		$85.4K Sell
62,828
-9,792
-13% -$20.8K ﹤0.01% 3358
2023
Q4 		$190K Buy
72,620
+65,336
+897% +$158K ﹤0.01% 2807
2023
Q3 		$23.3K Buy
+7,284
New +$33.9K ﹤0.01% 3107
2022
Q4 		– Sell
-32,418
Closed -$146K – 2440
2022
Q3 		$146K Buy
32,418
+5,643
+21% +$40.4K ﹤0.01% 1865
2022
Q2 		$157K Buy
+26,775
New +$137K ﹤0.01% 1790

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s APYX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Apyx Medical (APYX) stake by 86% in Q2 2026, selling an estimated $273K and leaving 11,652 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3118.

Qube Research & Technologies (QRT) first reported a position in APYX in Q2 2022 and has held it in 9 quarters since. The position peaked at $328K in Q4 2025. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 11,652 shares of Apyx Medical worth $52.3K as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 68,736 Apyx Medical shares in Q2 2026, an estimated $273K.
  • Apyx Medical made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3118 holding.
  • Qube Research & Technologies (QRT) first reported a position in Apyx Medical in Q2 2022 and has held it in 9 quarters since.
  • Qube Research & Technologies (QRT)'s Apyx Medical position peaked at $328K in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.